Amarin Corp Plcuk (AMRN) Accounts Payables (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Accounts Payables of $18.8 million for Q2 2026, down 57.96% year-over-year from $44.7 million in Q2 2025, and down 60.97% quarter-over-quarter from $48.2 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Accounts Payables (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Accounts Payables for 17 consecutive years, with $18.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Accounts Payables fell 57.96% year-over-year to $18.8 million; the TTM figure through Jun 2026 stood at $18.8 million (down 57.96% YoY), while the FY2025 annual figure was $45.4 million, up 12.36% from the prior year.
- Accounts Payables eased to $18.8 million in Q2 2026 per AMRN's latest filing, from $48.2 million in the prior quarter.
- Across five years, Accounts Payables topped out at $116.3 million in Q2 2022 and bottomed at $18.8 million in Q2 2026.
- Historically, Accounts Payables has averaged $57.0 million across 5 years, with a median of $53.1 million in 2023.
- Annual changes were most pronounced in 2022 — Accounts Payables climbed 28.64% — and 2026, when it plunged 57.96%.
- Amarin Corp Plc\Uk's Accounts Payables stood at $64.6 million in 2022, then retreated by 18.33% to $52.8 million in 2023, then fell by 23.49% to $40.4 million in 2024, then increased by 12.36% to $45.4 million in 2025, then tumbled by 58.56% to $18.8 million in 2026.
- Business Quant data shows AMRN's Accounts Payables at $18.8 million in Q2 2026, $48.2 million in Q1 2026, and $45.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 22.89 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -19.24 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | 18.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.80 Mn |
| Mar 31, 2026 | 48.15 Mn |
| Dec 31, 2025 | 45.36 Mn |
| Sep 30, 2025 | 36.71 Mn |
| Jun 30, 2025 | 44.71 Mn |
| Mar 31, 2025 | 45.66 Mn |
| Dec 31, 2024 | 40.37 Mn |
| Sep 30, 2024 | 40.51 Mn |
| Jun 30, 2024 | 54.38 Mn |
| Mar 31, 2024 | 67.60 Mn |
| Dec 31, 2023 | 52.76 Mn |
| Sep 30, 2023 | 53.36 Mn |
| Jun 30, 2023 | 54.31 Mn |
| Mar 31, 2023 | 58.78 Mn |
| Dec 31, 2022 | 64.60 Mn |
| Sep 30, 2022 | 93.16 Mn |
| Jun 30, 2022 | 116.31 Mn |
| Mar 31, 2022 | 90.75 Mn |
| Dec 31, 2021 | 114.92 Mn |
| Sep 30, 2021 | 72.42 Mn |